Active Ingredient History
Sirukumab is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6). Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 2)
COVID-19 (Phase 2)
Depressive Disorder, Major (Phase 2)
Giant Cell Arteritis (Phase 3)
Healthy Volunteers (Phase 1)
Lupus Erythematosus, Cutaneous (Phase 1)
Lupus Erythematosus, Systemic (Phase 1)
Lupus Nephritis (Phase 2)
Polymyalgia Rheumatica (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue